BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29182048)

  • 1. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging.
    Salehi S; Mohammar R; Suzuki C; Joneborg U; Hjerpe E; Torbrand C; Falconer H
    Acta Oncol; 2018 Jun; 57(6):820-824. PubMed ID: 29182048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer.
    Luger AK; Steinkohl F; Aigner F; Jaschke W; Marth C; Zeimet AG; Reimer D
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1092-1099. PubMed ID: 32112653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
    Prader S; Vollmar N; du Bois A; Heitz F; Schneider S; Ataseven B; Bommert M; Waltering KU; Heikaus S; Koch JA; Alesina PF; Traut A; Harter P
    Gynecol Oncol; 2019 Jan; 152(1):76-81. PubMed ID: 30463683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
    Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
    Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
    Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
    Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
    Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
    Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
    Hynninen J; Auranen A; Carpén O; Dean K; Seppänen M; Kemppainen J; Lavonius M; Lisinen I; Virtanen J; Grénman S
    Gynecol Oncol; 2012 Jul; 126(1):64-8. PubMed ID: 22542580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
    Signorelli M; Guerra L; Pirovano C; Crivellaro C; Fruscio R; Buda A; Cuzzucrea M; Elisei F; Ceppi L; Messa C
    Gynecol Oncol; 2013 Nov; 131(2):395-9. PubMed ID: 23988414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porta hepatis peritonectomy and hepato-celiac lymphadenectomy in patients with stage IIIC-IV ovarian cancer: Diagnostic pathway, surgical technique and outcomes.
    Tozzi R; Traill Z; Garruto Campanile R; Ferrari F; Soleymani Majd H; Nieuwstad J; Hardern K; Gubbala K
    Gynecol Oncol; 2016 Oct; 143(1):35-39. PubMed ID: 27519966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of CT detected enlarged cardiophrenic nodes in ovarian cancer patients.
    Oommen I; Chandramohan A; Raji PS; Thomas A; Joel A; Samuel Ram T; Peedicayil A
    Abdom Radiol (NY); 2021 Jan; 46(1):331-340. PubMed ID: 32577780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation.
    Nasser S; Lazaridis A; Evangelou M; Jones B; Nixon K; Kyrgiou M; Gabra H; Rockall A; Fotopoulou C
    Gynecol Oncol; 2016 Nov; 143(2):264-269. PubMed ID: 27586894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer.
    Nuruzzaman HSM; Tan GHC; Nadarajah R; Teo M
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29331996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
    LaFargue CJ; Bristow RE
    Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
    Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
    Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
    Fruscio R; Sina F; Dolci C; Signorelli M; Crivellaro C; Dell'Anna T; Cuzzocrea M; Guerra L; Milani R; Messa C
    Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
    Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
    Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Advanced-Stage Epithelial Ovarian Cancer Patients with Cardiophrenic Lymphadenopathy Who Underwent Cytoreductive Surgery: A Systematic Review and Meta-Analysis.
    Kengsakul M; Nieuwenhuyzen-de Boer GM; Bijleveld AHJ; Udomkarnjananun S; Kerr SJ; Niehot CD; van Beekhuizen HJ
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.